Granulomatous meningitis secondary to Avitene (microfibrillar collagen)
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 6, 2016
- Accepted August 16, 2016
- First Published September 14, 2016.
Article Versions
- Previous version (September 14, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Swetha Renati, MD,
- Supreet Kaur, MD,
- Jesse L. Kresak, MD,
- Meredith Wicklund, MD and
- Irene Malaty, MD
- Swetha Renati, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Supreet Kaur, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jesse L. Kresak, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Meredith Wicklund, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Florida Department of Health Ed and Ethel Moore Alzheimer?s Disease Research Program, grant #6AZ07, Principal Investigator,2016-2018 2) Florida Department of Health Ed and Ethel Moore Alzheimer?s Disease Research Program, grant # 6AZ10 and 6AZ15;, co-investigator, 2016-2018 2)Florida Department of Health Ed and Ethel Moore Alzheimer?s Disease Research Program, grant #5AZ01, 5AZ02, and 5AZ03; co-investigator, 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Irene Malaty, MD
NONE
Speaker reimbursement or stipend: National Parkinson Foundation, Tourette Association of America
(1) National Parkinson Foundation- received travel compensation for attending meetings (2) Tourette syndrome association- received honoraria and travel compensation for speaking (3) American Speech-Language-Hearing Association- I will receive honoraria for speaking
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)Abbott/ AbbVie- SubInvestigator in research funded by (University of Florida receives funding for research participation) (2)Auspex- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (3)Biotie- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (4)Merz- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (5)Neurocrine- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (6)Pfizer- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (7) Revance- Sub-Investigator in research funded by (University of Florida receives funding for research participation) (8) Teva- Site Primary Investigator in research funded by (University of Florida receives funding for research participation)
NONE
NONE
(1)National Parkinson Foundation- medical directer of Center of Excellence at UF, participant in Quality Improvement Initiative (2)Tourette Syndrome Association- medical advisory board (unpaid); participant in research funded by TSA for which UF received funding (3)Dystonia coalition
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to:
Swetha.renati{at}neurology.ufl.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Primary angiitis of the central nervous system associated with cerebral amyloid angiopathyReport of two cases and review of the literatureNathan B. Fountain, David A. Eberhard et al.Neurology, January 01, 1996 -
Brief Communications
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapyW. B. Pope, A. Lai, P. Nghiemphu et al.Neurology, April 24, 2006 -
Articles
The role of platelets in ischemic strokeGregory J. del Zoppo et al.Neurology, September 01, 1998 -
ARTICLES
The prognostic impact of prior low grade histology in patients with anaplastic gliomasA case-control studyEdward J. Dropcho, Seng-jaw Soong et al.Neurology, September 01, 1996